Sierra Oncology Inc (SRRA) stock has gained 203.62% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives SRRA stock a score of 67 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 100. SRRA's rank also includes a short-term technical score of 99. The fundamental score for SRRA is 3. In addition to the average rating from Wall Street analysts, SRRA stock has a mean target price of $52.20. This means analysts expect the stock to fall 4.27% over the next 12 months. SRRA has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on SRRA!